• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病:1型和2型糖尿病患者相同的病因因素

Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.

作者信息

de Vries Marieke, El-Morabit Fatima, van Erpecum Karel J, Westerink Jan, Bac Simon T, Kaasjager H A H Karin, de Valk Harold W

机构信息

Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.

Department of Gastroenterology, University Medical Center Utrecht, Utrecht, the Netherlands.

出版信息

Eur J Intern Med. 2022 Jun;100:77-82. doi: 10.1016/j.ejim.2022.03.025. Epub 2022 Apr 3.

DOI:10.1016/j.ejim.2022.03.025
PMID:35387749
Abstract

AIMS

To compare NAFLD prevalence, distribution and its etiologic determinants in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D).

METHODS

In this cross-sectional study, NAFLD was evaluated by transient elastography in adult outpatients with T1D and T2D. NAFLD was defined as hepatic steatosis with or without fibrosis. Associations between insulin resistance related factors and NAFLD and advanced fibrosis (≥ F3) were explored in T1D and T2D separately, using multivariate logistic regression models. Interaction analysis was performed to compare the associations in patients with T1D and T2D.

RESULTS

One hundred and fifty patients with T1D (mean age 47 years, male 55%, mean diabetes duration 25 years, median BMI 25 kg/m) and 100 patients with T2D (median age 67 years, male 56%, median diabetes duration 17 years, mean BMI 30 kg/m) were included. NAFLD prevalence was 20% in patients with T1D and 76% in patients with T2D. Advanced fibrosis prevalence was 2.0% in patients with T1D and 22% in patients with T2D. In both patients with T1D and T2D, waist circumference, BMI and metabolic syndrome were positively associated, and estimated insulin sensitivity was negatively associated with the presence of NAFLD, adjusted for age, sex and diabetes duration. There was no effect modification by diabetes type for any of these associations.

CONCLUSIONS

Despite differences in population characteristics and pathophysiology between T1D and T2D, insulin resistance related factors are similarly associated with NAFLD in both groups.

摘要

目的

比较1型糖尿病(T1D)和2型糖尿病(T2D)患者的非酒精性脂肪性肝病(NAFLD)患病率、分布情况及其病因决定因素。

方法

在这项横断面研究中,通过瞬时弹性成像技术对成年T1D和T2D门诊患者进行NAFLD评估。NAFLD定义为伴有或不伴有纤维化的肝脂肪变性。分别在T1D和T2D患者中,使用多因素逻辑回归模型探讨胰岛素抵抗相关因素与NAFLD及进展性纤维化(≥F3)之间的关联。进行交互分析以比较T1D和T2D患者中的关联。

结果

纳入了150例T1D患者(平均年龄47岁,男性占55%,平均糖尿病病程25年,BMI中位数25kg/m)和100例T2D患者(年龄中位数67岁,男性占56%,糖尿病病程中位数17年,平均BMI 30kg/m)。T1D患者的NAFLD患病率为20%,T2D患者为76%。T1D患者的进展性纤维化患病率为2.0%,T2D患者为22%。在T1D和T2D患者中,调整年龄、性别和糖尿病病程后,腰围、BMI和代谢综合征与NAFLD呈正相关,估计的胰岛素敏感性与NAFLD的存在呈负相关。这些关联中没有任何一种受糖尿病类型的影响修饰作用。

结论

尽管T1D和T2D在人群特征和病理生理学方面存在差异,但两组中胰岛素抵抗相关因素与NAFLD的关联相似。

相似文献

1
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.非酒精性脂肪性肝病:1型和2型糖尿病患者相同的病因因素
Eur J Intern Med. 2022 Jun;100:77-82. doi: 10.1016/j.ejim.2022.03.025. Epub 2022 Apr 3.
2
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.非酒精性脂肪性肝病(NAFLD)在 1 型糖尿病和 2 型糖尿病患者中的患病率及其与代谢的相关性。
Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22.
3
Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes.1型糖尿病患者中非酒精性脂肪性肝病(NAFLD)的患病率及其与胰岛素抵抗替代指标的关联。
Diabetes Res Clin Pract. 2022 Apr;186:109827. doi: 10.1016/j.diabres.2022.109827. Epub 2022 Mar 10.
4
Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.新诊断酮症起病糖尿病患者中非酒精性脂肪性肝病的患病率及临床特征。
Diabetes Metab. 2018 Nov;44(5):437-443. doi: 10.1016/j.diabet.2018.03.002. Epub 2018 Mar 21.
5
Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes.甲状腺功能与新发糖尿病患者非酒精性脂肪性肝病的相关性。
Liver Int. 2024 Jan;44(1):27-38. doi: 10.1111/liv.15723. Epub 2023 Sep 12.
6
Association of physical activity and sports participation with insulin resistance and non-alcoholic fatty liver disease in people with type 1 diabetes.1 型糖尿病患者身体活动和运动参与与胰岛素抵抗和非酒精性脂肪肝的关系。
Diabet Med. 2024 Jul;41(7):e15317. doi: 10.1111/dme.15317. Epub 2024 Apr 8.
7
The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.1 型糖尿病儿童和青少年中非酒精性脂肪性肝病的患病率及其危险因素。
J Pediatr. 2021 Mar;230:32-37.e1. doi: 10.1016/j.jpeds.2020.10.043. Epub 2020 Oct 24.
8
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.美国 2 型糖尿病、糖尿病前期、代谢不健康和代谢健康个体中非酒精性脂肪性肝病(NAFLD)和相关死亡率。
Metabolism. 2023 Sep;146:155642. doi: 10.1016/j.metabol.2023.155642. Epub 2023 Jun 26.
9
Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.胎球蛋白-B 通过诱导胰岛素抵抗将非酒精性脂肪性肝病与 2 型糖尿病联系起来:关联和路径分析。
Cytokine. 2018 Aug;108:145-150. doi: 10.1016/j.cyto.2018.03.023. Epub 2018 Mar 30.
10
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.动脉粥样硬化性血脂异常,而不是高血糖,是与 2 型糖尿病和非酒精性脂肪性肝病患者肝纤维化相关的独立因素:一项基于人群的研究。
Eur J Endocrinol. 2021 Apr;184(4):587-596. doi: 10.1530/EJE-20-1240.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention.代谢功能障碍相关脂肪性肝病:心血管风险的隐匿驱动因素及新的干预靶点
Int J Mol Sci. 2025 Aug 21;26(16):8081. doi: 10.3390/ijms26168081.
2
The Efficacy of Home-based Resistance Exercise and Game-based Exercise Training on microRNA-21-5p Expression and Non-Alcoholic Fatty Liver Biomarkers in Children with Type 1 Diabetes.家庭抗阻运动和游戏式运动训练对1型糖尿病儿童微小RNA-21-5p表达及非酒精性脂肪肝生物标志物的影响
Adv Biomed Res. 2025 Jul 31;14:71. doi: 10.4103/abr.abr_105_24. eCollection 2025.
3
Classification of Japanese type 1 diabetes based on clinical phenotypes and its association with diabetic complications: Across-sectional study.
基于临床表型的日本1型糖尿病分类及其与糖尿病并发症的关联:一项横断面研究。
J Diabetes Investig. 2025 Sep;16(9):1653-1662. doi: 10.1111/jdi.70108. Epub 2025 Jul 2.
4
CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease.CXCL12作为N-乙酰半胱氨酸治疗1型糖尿病肝病的潜在关键基因。
Biomolecules. 2025 Jan 25;15(2):176. doi: 10.3390/biom15020176.
5
An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences.2型糖尿病和非酒精性脂肪性肝病对心血管后果的叠加影响的见解。
Mol Biol Rep. 2025 Jan 28;52(1):169. doi: 10.1007/s11033-025-10249-0.
6
The probiotic Lacticaseibacillus rhamnosus SD11 alleviates the progression of liver and colon damage through modulation of inflammation and tight junction proteins in streptozotocin-induced diabetic mice.益生菌鼠李糖乳杆菌 SD11 通过调节链脲佐菌素诱导的糖尿病小鼠的炎症和紧密连接蛋白来缓解肝和结肠损伤的进展。
PLoS One. 2024 Nov 21;19(11):e0313395. doi: 10.1371/journal.pone.0313395. eCollection 2024.
7
Type 1 diabetes and combined acute and chronic complications are associated with risk of progression of liver fibrosis: a Mendelian randomization study.1 型糖尿病及其合并的急慢性并发症与肝纤维化进展风险相关:一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Aug 5;15:1302611. doi: 10.3389/fendo.2024.1302611. eCollection 2024.
8
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping.代谢功能障碍相关脂肪性肝病的异质性:亚型分类的必要性。
World J Gastrointest Pathophysiol. 2024 May 24;15(2):92791. doi: 10.4291/wjgp.v15.i2.92791.
9
Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease.胃内球囊联合生活方式改变:代谢相关脂肪性肝病伴超重和肥胖患者的一种有前途的治疗选择。
Intern Emerg Med. 2023 Nov;18(8):2271-2280. doi: 10.1007/s11739-023-03417-2. Epub 2023 Sep 12.
10
Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease.氧化应激和癌胚抗原相关细胞黏附分子 1 在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2023 Jul 10;24(14):11271. doi: 10.3390/ijms241411271.